ScholarLens Back to search
2014•Dermatology TimesRequires access

Update: Actinic Keratoses | Guidelines aim to standardize, advance actinic keratoses treatments

Cheryl Guttman Krader

Open publisher page 0 citations

Abstract

Dermatologists and other medical specialists around the world who treat patients with actinic keratoses (AKs or solar keratoses) will soon be able to refer to new evidence-based (S3) guidelines for management.

About this research paper

What this paper is about

Dermatologists and other medical specialists around the world who treat patients with actinic keratoses (AKs or solar keratoses) will soon be able to refer to new evidence-based (S3) guidelines for management.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Dermatologists and other medical specialists around the world who treat patients with actinic keratoses (AKs or solar keratoses) will soon be able to refer to new evidence-based (S3) guidelines for management.

Key concepts: Actinic keratoses, Medicine, Dermatology, Basal cell, Pathology

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Update: Actinic Keratoses | Guidelines aim to standardize, advance actinic keratoses treatments — Research Paper | ScholarLens